Toggle navigation
Our Platform
Our Platform
Radioligand Therapy
Peptide-Drug Conjugate Program
SOR-C13 TRPV6 Inhibitor
Science
The Target: TRPV6
Mechanism of Action
Intellectual Property
About
Our Team
For Investors
News and Events
Resources
Contact
Toggle navigation
Our Platform
Our Platform
Radioligand Therapy
Peptide-Drug Conjugate Program
SOR-C13 TRPV6 Inhibitor
Science
The Target: TRPV6
Mechanism of Action
Intellectual Property
About
Our Team
For Investors
News and Events
Resources
Contact
Soricimed Biopharma
Resources
Publications
Poster Presentations
No matching articles found.
Sign up to receive updates from Soricimed
Submit
Powered by Innovasium
